<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04224467</url>
  </required_header>
  <id_info>
    <org_study_id>NFEC-2019-242</org_study_id>
    <nct_id>NCT04224467</nct_id>
  </id_info>
  <brief_title>The Application of Real-Time Near-infrared Imaging in Gynecological Surgery</brief_title>
  <official_title>Real-Time Identification of Lesions and Nerves by Using Indocyanine Green Fluorescent Imaging in Gynecological Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chen Chunlin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Southern Medical University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Removing in situ and metastasis lesions completely during gynecological surgery is central to
      reduce the recurrence and death, and the identification of lesions in traditional
      gynecological surgery often depends on the experience of surgeons. The identification of
      nerves is often needed in gynecological surgery, such as the obturator nerves in pelvic
      lymphadenectomy, and the pelvic autonomic nerves in nerve-sparing radical hysterectomy for
      cervical cancer. Nerve identification also relies heavily on the experience of surgeons. This
      project aims to realize the identification of lesions and nerves under the navigation of
      indocyanine green fluorescent imaging, and evaluate the accuracy of fluorescent imaging of
      lesions and the effectiveness of nerves identification by near-infrared imaging. This project
      may reduce the recurrence or death caused by residual lesions and postoperative dysfunction
      caused by nerves injury, thus, improve the survival rate and quality of life for patients
      with gynecological diseases.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">November 2024</completion_date>
  <primary_completion_date type="Anticipated">November 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The value and feasibility of real-time near-infrared imaging in the identification of lesions</measure>
    <time_frame>4 years</time_frame>
    <description>Evaluation of the effectiveness of real-time near-infrared imaging in detecting the margin of in situ lesions, whether there is metastasis lesions and whether the metastasis lesions has been completely removed , lymph node metastasis or not during gynecological surgery. The criteria of evaluation is postoperative pathological results and fluorescence intensity of specimen sections measured by laser scanning confocal microscope.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The value and feasibility of real-time near-infrared imaging in the identification of nerves</measure>
    <time_frame>4 years</time_frame>
    <description>Evaluation of the effectiveness of real-time near-infrared imaging in detecting nerves associated with gynecological surgery, including the pelvic autonomic nerves composed of the abdominal aortic plexus, the superior hypogastric plexus, the hypogastric nerves, the pelvic splanchnic nerves, the inferior hypogastric plexus and its branches, obturator nerves, genitofemoral nerve, etc.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Cervical Cancer</condition>
  <condition>Ovarian Tumor</condition>
  <condition>Endometrial Carcinoma</condition>
  <condition>Uterine Myomatosis</condition>
  <condition>Adenomyosis</condition>
  <condition>Ovarian Cyst Benign</condition>
  <condition>Ovarian Cyst Malignant</condition>
  <condition>Endometriosis</condition>
  <condition>Uterine Sarcoma</condition>
  <arm_group>
    <arm_group_label>Indocyanine Green Fluorescent Imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be intravenously injected ICG (Yichuang Pharmaceutical Limited Liability Company, Dandong, China) at a dose of 2-5 mg per kg of body weight before surgery or 0.25-0.5 mg per kg of body weight during surgery. Then, a NIR imaging systems included the NIR (800-900 nm) and white-light (400-650nm) dual-channel will be used to detect In situ lesions, metastatic lesions, lymph nodes, obturator nerve, pelvic autonomic nerve, etc during surgery according to disease and clinical needs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intravenous ICG and Real-Time Near-infrared Imaging</intervention_name>
    <description>Patients will be intravenously injected ICG (Yichuang Pharmaceutical Limited Liability Company, Dandong, China) at a dose of 2-5 mg per kg of body weight before surgery or 0.25-0.5 mg per kg of body weight during surgery. Then real-time near-infrared imaging will be conducted during surgery.</description>
    <arm_group_label>Indocyanine Green Fluorescent Imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with FIGO (2018) stage IA1(LVSI)-IIA2 cervical cancer，endometrial
             cancer，ovarian tumor, endometriosis, adenomyosis, uterine myomatosis, ovarian cyst ,or
             uterine sarcoma

          -  Patients who consent to receive indocyanine green near-infrared fluorescence-guided
             gynecological surgery

        Exclusion Criteria:

          -  Less than 6 months expectancy life;

          -  Patients with iodine allergy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chunlin Chen, MD/PhD</last_name>
    <phone>+8613725263051</phone>
    <email>ccl1@smu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Southern Medical Universtity, China</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>chunlin chen, MD/PhD</last_name>
      <phone>+8613725263051</phone>
      <email>ccl1@smu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Seracchioli R, Raimondo D, Arena A, Zanello M, Mabrouk M. Clinical use of endovenous indocyanine green during rectosigmoid segmental resection for endometriosis. Fertil Steril. 2018 Jun;109(6):1135. doi: 10.1016/j.fertnstert.2018.02.122.</citation>
    <PMID>29935649</PMID>
  </results_reference>
  <results_reference>
    <citation>Gossedge G, Vallance A, Jayne D. Diverse applications for near infra-red intraoperative imaging. Colorectal Dis. 2015 Oct;17 Suppl 3:7-11. doi: 10.1111/codi.13023. Review.</citation>
    <PMID>26394736</PMID>
  </results_reference>
  <results_reference>
    <citation>Cosentino F, Vizzielli G, Turco LC, Fagotti A, Cianci S, Vargiu V, Zannoni GF, Ferrandina G, Scambia G. Near-Infrared Imaging with Indocyanine Green for Detection of Endometriosis Lesions (Gre-Endo Trial): A Pilot Study. J Minim Invasive Gynecol. 2018 Nov - Dec;25(7):1249-1254. doi: 10.1016/j.jmig.2018.02.023. Epub 2018 Mar 15.</citation>
    <PMID>29551477</PMID>
  </results_reference>
  <results_reference>
    <citation>Malzoni M, Iuzzolino D, Rasile M, Coppola M, Casarella L, Di Giovanni A, Falcone F. Surgical Principles of Segmental Rectosigmoid Resection and Reanastomosis for Deep Infiltrating Endometriosis. J Minim Invasive Gynecol. 2020 Feb;27(2):258. doi: 10.1016/j.jmig.2019.06.018. Epub 2019 Jul 17.</citation>
    <PMID>31325591</PMID>
  </results_reference>
  <results_reference>
    <citation>He K, Zhou J, Yang F, Chi C, Li H, Mao Y, Hui B, Wang K, Tian J, Wang J. Near-infrared Intraoperative Imaging of Thoracic Sympathetic Nerves: From Preclinical Study to Clinical Trial. Theranostics. 2018 Jan 1;8(2):304-313. doi: 10.7150/thno.22369. eCollection 2018.</citation>
    <PMID>29290809</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen SC, Wang MC, Wang WH, Lee CC, Yang TF, Lin CF, Wang JT, Liao CH, Chang CC, Chen MH, Shih YH, Hsu SP. Fluorescence-assisted visualization of facial nerve during mastoidectomy: A novel technique for preventing iatrogenic facial paralysis. Auris Nasus Larynx. 2015 Apr;42(2):113-8. doi: 10.1016/j.anl.2014.08.008. Epub 2014 Sep 6.</citation>
    <PMID>25199746</PMID>
  </results_reference>
  <results_reference>
    <citation>Mao Y, Chi C, Yang F, Zhou J, He K, Li H, Chen X, Ye J, Wang J, Tian J. The identification of sub-centimetre nodules by near-infrared fluorescence thoracoscopic systems in pulmonary resection surgeries. Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1190-1196. doi: 10.1093/ejcts/ezx207.</citation>
    <PMID>28950327</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 8, 2020</study_first_submitted>
  <study_first_submitted_qc>January 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>January 12, 2020</last_update_submitted>
  <last_update_submitted_qc>January 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Southern Medical University, China</investigator_affiliation>
    <investigator_full_name>Chen Chunlin</investigator_full_name>
    <investigator_title>Department of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cysts</mesh_term>
    <mesh_term>Endometrial Neoplasms</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Ovarian Cysts</mesh_term>
    <mesh_term>Endometriosis</mesh_term>
    <mesh_term>Adenomyosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

